63例儿童阵发性室上性心动过速急诊药物复律的分析  

Analysis of Emergency Drug Treatment for 63 Children with Paroxysmal Supraventricular Tachycardia

作　　者：诸凌涛 

机构地区：[1]常州市第一人民医院儿科,江苏常州213003

出　　处：《中国血液流变学杂志》2015年第4期489-491,共3页Chinese Journal of Hemorheology

摘　　要：目的：对儿童阵发性室上性心动过速（PSVT）急诊药物复律的效果进行临床分析，以进一步提高对儿童PSVT急诊诊治的认识。方法2013年1月—2015年1月急诊儿科对63例PSVT患儿分别采用ATP（n=32）、心律平（n=25）、胺碘酮（n=6）进行了急诊药物复律，回顾性分析三种复律药物的复律成功率、并发症和不良反应、复发情况，并进行对比研究。结果三种复律药物在复律成功率、并发症和不良反应、复发情况方面差异均无统计学意义。结论 ATP、心律平、胺碘酮作为PSVT的急诊常规复律药物可以被推广使用，但是要求急诊儿科医师熟练掌握各种复律药物的适应证及禁忌证，选择最合适的复律药物，做到合理用药。Objective Analysing the effect of different cardioversion conversion drugs treating children with paroxysmal supraventricular tachycardia （PSVT）, to improve the recognition of emergency diagnosis and treatment for children with PSVT. Methods From January 2013 to January 2015, 63 children with PSVT were treated with emergency pharmacological cardioversion in our Pediatric Emergency Room, respectively using ATP （n=32）, Propafenone （n=25）, and Amiodarone （n=6） for retrospective analyzing and contrasting the clinical effects, adverse reactions and recurrent events. Results There is no significant difference on the clinical effects, adverse reactions and recurrent events for the three cardioversion conversion drugs. Conclusion ATP, Propafenone and Amiodarone can be widely used on the pharmacological cardioversion for children with PSVT, however, the emergency pediatrician should perfect themselves in the indication and contraindication of different cardioversion conversion drugs, choosing the most suitable cardioversion conversion drugs, and rational use of the drugs.

关 键 词：阵发性室上性心动过速 药物复律 儿童 PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) 

分 类 号：R725.4[医药卫生—儿科]